Amir Sabet

14PUBLICATIONS
18CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Radiation therapyPsychosocial aspects of childbirth and perinatal mental healthInstruments and techniques
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Dec 06, 2024
Cancer-Control Outcomes of Patients With Metastatic Castration-Resistant Prostate Cancer With BRCA Gene or Tumor Suppressor Mutations Undergoing 177-Lutetium Prostate-Specific Membrane Antigen Radioligand Therapy.

Mike Wenzel, Florestan Koll, Benedikt Hoeh

|Jan 23, 2024
Safety and Efficacy of Selective Internal Radionuclide Therapy with 90Y Glass Microspheres in Patients with Progressive Hepatocellular Carcinoma after the Failure of Repeated Transarterial Chemoembolization.

Alexander Bellendorf, Nicolai Mader, Stefan P Mueller

|Sep 28, 2023
Intermittent Radioligand Therapy with 177Lu-PSMA-617 for Oligometastatic Castration-Resistant Prostate Cancer.

Nicolai Mader, Christina Schoeler, Niloufar Pezeshkpour

|Aug 12, 2023
Impact of [177Lu]Lu-PSMA-617 Radioligand Therapy on Reference Organ Uptake Assessed by [68Ga]Ga-PSMA-11-PET/CT.

Daniel Groener, Jennifer Wichert, Magdalena Adams

|Jan 26, 2023
Extended therapy with [177Lu]Lu-PSMA-617 in responding patients with high-volume metastatic castration-resistant prostate cancer.

Nicolai Mader, Christina Nguyen Ngoc, Bilge Kirkgöze

|Jan 21, 2023
Baseline [68Ga]Ga-PSMA-11 PET/CT before [177Lu]Lu-PSMA-617 Radioligand Therapy: Value of PSMA-Uptake Thresholds in Predicting Targetable Lesions.

Daniel Groener, Sina Schneider, Justus Baumgarten

Pageof 3

Frequent Collaborators

8 joint publications

Daniel Gröner

8 joint publications

Nicolai Mader

4 joint publications

Samer Ezziddin

3 joint publications

Fadi Khreish